Rider for the Israeli Tour de France team suspended after positive drug test
search

The latest Jewish News

Read this week’s digital edition

Click Here

Rider for the Israeli Tour de France team suspended after positive drug test

Swiss rider Patrick Schelling, who is part of the Israel Start-Up Nation squad, tested positive for terbutaline, a banned substance found in asthma inhalers

Israel Start-Up Nation team (photo Dario Belingheri/BettiniPhoto©2020)
Israel Start-Up Nation team (photo Dario Belingheri/BettiniPhoto©2020)

A rider for the Israel Start-Up Nation cycling team was banned from cycling for four months after failing a drug test.

Swiss rider Patrick Schelling is part of the Israel Start-Up Nation team, which is making its first appearance in the Tour de France. Schelling is not one of the team members riding in the race. He tested positive for terbutaline, a banned substance found in asthma inhalers, Cycling News reported.

The International Cycling Union is characterizing the offense as a “non-intentional anti-doping rule violation.”

The positive test occurred on Feb. 24, in Stage 2 of the Tour de Rwanda. The ban is retroactive to May 18 and ends on Sept. 17.

Schelling, 30, said he has had asthma since he was a child and apologized for using a non-allowed asthma spray.

The Israeli team said in a statement that Schelling had not told them he was taking asthma medication.

“We accept the sanction by the UCI, which was imposed in accordance with the Anti-Doping Rules. ISN will deal with this internally to ensure that such violations are not repeated,” the statement said.

Guy Niv, 26, a member of Team Start-Up Israel, became the first Israeli to compete in the Tour de France.

Israelis will race in two other Grand Tour races later this year: Guy Sagiv in the Giro d’Italia and Omer Goldstein in the Vuelta a Espana.

read more:
comments